GURU.Markets stock price, segment price, and overall market index valuation
The company's share price AKYA
Akoya Biosciences produces spatial biology tools that allow scientists to analyze cells in the context of their tissue environment. Its stock price reflects a bet that its technology will become a new standard in biomedical research, particularly in oncology.
Share prices of companies in the market segment - Diagnostic medical equipment
Akoya Biosciences provides comprehensive solutions for spatial biology, enabling scientists to visualize cells and biomarkers in tissues at high resolution. We've categorized it as "Diagnostic Equipment." The chart below shows how the market values โโthese advanced research tools.
Broad Market Index - GURU.Markets
Akoya Biosciences is a life sciences company that provides spatial biology platforms, allowing researchers to study cells in their tissue environments. As a component of the GURU.Markets index, it is at the forefront of scientific advancement. The chart below represents the entire market. See how this company's stock compares to the overall trend.
Change in the price of a company, segment, and market as a whole per day
AKYA - Daily change in the company's share price AKYA
Akoya Biosciences, Inc.'s daily share price fluctuations reflect volatility in the life sciences sector. This metric measures the company's sensitivity to demand for its spatial biology platforms from research laboratories.
Daily change in the price of a set of shares in a market segment - Diagnostic medical equipment
Akoya Biosciences offers spatial biology solutions, enabling researchers to visualize cells in tissues with high precision. This is a cutting-edge sector of biotechnology. The chart below shows the volatility in this niche, reflecting the high potential and risks associated with AKYA's developments.
Daily change in the price of a broad market stock, index - GURU.Markets
Akoya Biosciences is a life sciences company producing platforms for spatial biology. This innovative company's shares reflect progress in biomedical research. Their volatility is part of the dynamics of the innovation sector.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization AKYA
Akoya Biosciences' year-over-year performance tells the story of its role in spatial biology. Its market capitalization growth over the past 12 months reflects demand from scientific laboratories for its systems, which allow cells to be studied in the context of their tissue environment, a breakthrough for oncology and immunology research.
Annual dynamics of market capitalization of the market segment - Diagnostic medical equipment
Akoya Biosciences is a life sciences company providing spatial biology platforms that enable the study of cells in their natural environment. The graph shows how its technological leadership and reliance on R&D budgets enable its accelerated growth.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Akoya Biosciences, a company providing spatial biology solutions, allows scientists to visualize how cells interact within tissues. Its annual market capitalization dynamics reflect the demand for cutting-edge research tools in pharmaceuticals and biotechnology, betting on future scientific discoveries.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization AKYA
Akoya is a biotechnology company producing systems for spatial biology. Its monthly performance reflects the pace of adoption of its platforms in research labs and growing sales of consumables, which are key to its business model.
Monthly dynamics of market capitalization of the market segment - Diagnostic medical equipment
Akoya Biosciences provides spatial biology platforms that enable scientists to visualize and analyze cells in their natural tissue environments. The graph below shows the overall dynamics in the diagnostic equipment sector, where Akoya is a pioneer.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Akoya Biosciences supplies spatial biology equipment, allowing scientists to visualize cells in their natural environment. It's a high-tech company whose success depends on R&D budgets in the pharmaceutical and scientific industries. Its stock price is a barometer of investment in the future of biotech discoveries.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization AKYA
Shares of Akoya Biosciences, a spatial biology company, reflect trends in biomedical research. Weekly price movements depend on news about the sales of their equipment and its use in scientific discoveries. The chart below shows how short-term events at the forefront of science influence the valuation of this technology player.
Weekly dynamics of market capitalization of the market segment - Diagnostic medical equipment
Akoya Biosciences produces spatial biology tools that allow the study of cells in their natural environment. This is a revolution in medical research. The chart below shows how expectations for this breakthrough technology are impacting the company's stock, setting it apart from the medical device sector.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Akoya Biosciences is a biotech company. This chart compares its weekly volatility with the market. It shows how its stock, like other early-stage companies, is driven by news of scientific breakthroughs rather than by overall market trends.
Market capitalization of the company, segment and market as a whole
AKYA - Market capitalization of the company AKYA
Akoya Biosciences, Inc.'s valuation on the chart is a bet on its spatial biology platforms, which allow scientists to visualize how cells interact within tissue. The company's market capitalization depends on demand for its equipment from pharmaceutical and research labs. Its growth reflects the growth of this emerging scientific field.
AKYA - Share of the company's market capitalization AKYA within the market segment - Diagnostic medical equipment
Akoya Biosciences' market share in the medical devices sector reflects its leadership in spatial biology. Its market share is driven by its platforms, which allow scientists to visualize how cells interact within tissue, revolutionizing oncology and immunology.
Market capitalization of the market segment - Diagnostic medical equipment
Here's a chart of the total market capitalization of biotech companies developing tools for spatial biology. Akoya Biosciences is one of the leaders in this revolutionary field. The graph shows how the market values โโtechnologies that allow us to see cells in their natural environment.
Market capitalization of all companies included in a broad market index - GURU.Markets
This chart visualizes the market value of a cancer microscope. Akoya Biosciences' market cap reflects the valuation of its spatial biology platform, which allows for viewing cells in their natural environment. The line shows how breakthroughs in research shape the future of medicine.
Book value capitalization of the company, segment and market as a whole
AKYA - Book value capitalization of the company AKYA
Akoya Biosciences' book value represents its scientific and technological capital. The chart below reflects the valuation of its patents for spatial biology platforms (Phenoptics and CODEX), which enable the study of cells in the context of tissues. The growth of the line reflects investments in these breakthrough research tools.
AKYA - Share of the company's book capitalization AKYA within the market segment - Diagnostic medical equipment
Akoya Biosciences' core assets are its production lines for creating instruments and reagents for spatial biology. The chart shows the company's share of this innovative production infrastructure, which allows scientists to visualize cells in their natural environment.
Market segment balance sheet capitalization - Diagnostic medical equipment
The life sciences sector, as the chart shows, requires unique assets. Akoya Biosciences is a prime example. Its business is capital-intensive, requiring manufacturing capabilities to create complex tools for spatial biology.
Book value of all companies included in the broad market index - GURU.Markets
Akoya Biosciences produces spatial biology tools that allow scientists to visualize how cells interact within tissues. The company's assets are factories that create "mapping" systems for the world of biology. The graph illustrates the material weight behind this research-changing technology.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - AKYA
Akoya Biosciences is a biotechnology company whose tools enable scientists to study cells in their natural environment. Its market value is derived from its unique technology, which accelerates medical discovery.
Market to book capitalization ratio in a market segment - Diagnostic medical equipment
Akoya Biosciences, Inc. provides spatial biology solutions, enabling scientists to visualize cells in tissues. Its value lies in this cutting-edge technology. This chart shows how its market valuation, reflecting the research potential of its platform, exceeds its assets by a multiple.
Market to book capitalization ratio for the market as a whole
Akoya Biosciences produces spatial biology equipment for analyzing cells in tissues. The company's market valuation, shown in this chart, is based on the potential of their unique technology. Investors are evaluating their potential to become a standard in biomedical research.
Debts of the company, segment and market as a whole
AKYA - Company debts AKYA
Akoya Biosciences, a company that produces spatial biology tools, is leveraging its financial structure to fund R&D and commercial expansion. This chart shows how the company is investing in the development of its platforms and reagents, which allow scientists to analyze cells in the context of tissues, a breakthrough in research.
Market segment debts - Diagnostic medical equipment
Akoya Biosciences provides a spatial biology platform that allows scientists to analyze cells in the context of their tissue environment. This chart shows how its leverage reflects its investment in R&D and commercialization of this cutting-edge technology, as well as its strategy to install its instruments in leading research labs worldwide.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio AKYA
Alternus Clean Energy develops and manages solar power parks. Green energy is a capital-intensive business, with each project costing millions. This chart shows the company's use of debt financing to build and acquire new solar assets worldwide.
Market segment debt to market segment book capitalization - Diagnostic medical equipment
Akoya Biosciences provides spatial biology solutions, enabling researchers to visualize cells and biomarkers in tissue. This chart compares its debt to the total market capitalization of the entire sector. It shows how this cutting-edge company funds its innovative biomedical research tools.
Debt to book value of all companies in the market
Akoya Biosciences provides solutions for spatial biology, allowing scientists to study cells within the context of tissues. This is a revolution in biomedical research. This chart of total market debt provides insight into the financial environment in which Akoya is funding its R&D and commercialization to make its platform a standard in laboratories worldwide.
P/E of the company, segment and market as a whole
P/E - AKYA
This chart shows the valuation of Akoya Biosciences, a life sciences company. Its high P/E reflects demand for its spatial biology platforms, which allow scientists to obtain unprecedented tissue data. This is a bet that its technology will become a new standard in research.
P/E of the market segment - Diagnostic medical equipment
Akoya Biosciences is a life sciences company that provides spatial biology solutions. Their platforms enable scientists to visualize and analyze the location of cells and biomarkers in tissues with high accuracy. This chart shows the average valuation for the diagnostic equipment sector, reflecting how investors value technologies that open new frontiers in research.
P/E of the market as a whole
Akoya Biosciences provides spatial biology solutions that enable researchers to visualize and analyze cells in their natural tissue environment. The company's technology accelerates discoveries in oncology and immunology. This risk appetite chart helps understand how investors value companies creating cutting-edge scientific tools.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company AKYA
Akoya Biosciences provides spatial biology solutions that enable scientists to study cells in the context of their tissue environment. This graph reflects future revenue expectations, which depend on demand for its tools in scientific research and the pharmaceutical industry.
Future (projected) P/E of the market segment - Diagnostic medical equipment
Akoya Biosciences provides spatial biology solutions, enabling scientists to visualize cells and biomarkers in tissues. This chart reflects how investors view its cutting-edge technology. It compares expectations for Akoya with other companies in the life sciences tools sector.
Future (projected) P/E of the market as a whole
Akoya Biosciences provides spatial biology solutions, enabling scientists to visualize cells in tissues with high accuracy. Demand for their platforms depends on research budgets. This trend, reflecting general sentiment, influences R&D funding at biotech and pharmaceutical companies, which are Akoya's key clients.
Profit of the company, segment and market as a whole
Company profit AKYA
Akoya Biosciences provides spatial biology solutions, enabling researchers to study cells in the context of tissues. Its revenue depends on R&D expenditures in academic and pharmaceutical laboratories. This chart shows how demand for advanced drug discovery research tools impacts the company's financial performance.
Profit of companies in the market segment - Diagnostic medical equipment
Akoya Biosciences provides spatial biology solutions, enabling researchers to visualize cells and biomarkers in tissues at high resolution. This graph, showing overall sector revenue, reflects breakthroughs in biomedical research. Akoya's technologies directly impact the speed and depth of scientific discovery, shaping the future of the entire industry.
Overall market profit
Akoya Biosciences provides spatial biology platforms that enable scientists to analyze cells and biomarkers within the context of their tissue location. This is a revolutionary technology for oncology and immunology research. The company's success depends on the implementation of its tools in laboratories worldwide.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company AKYA
Akoya Biosciences provides spatial biology solutions, enabling scientists to visualize cells in tissues. Future revenue projections depend on research spending in the pharmaceutical and academic sectors. Analysts are assessing demand for its innovative platforms.
Future (predicted) profit of companies in the market segment - Diagnostic medical equipment
Akoya Biosciences provides spatial biology solutions, enabling researchers to visualize cells and biomarkers in tissues at high resolution. This chart shows revenue forecasts for the medical diagnostics sector. It helps assess how the company's cutting-edge research technology compares to overall biomedical trends.
Future (predicted) profit of the market as a whole
Akoya Biosciences provides solutions for spatial tissue analysis, a breakthrough in biomedical research. Demand for its platforms depends on R&D budgets in the pharmaceutical and academic sectors. This timing is important, as during periods of growth and confidence, funding for science and medical research increases, benefiting Akoya.
P/S of the company, segment and market as a whole
P/S - AKYA
Akoya Biosciences provides spatial biology solutions, enabling researchers to visualize cells and biomarkers in tissues. This metric, which links market capitalization to sales, reflects its leadership in this emerging scientific field. It reflects the high premium investors are paying for its technology, which accelerates research in oncology and immunology.
P/S market segment - Diagnostic medical equipment
Akoya Biosciences provides spatial biology solutions that enable researchers to visualize and analyze cells in their natural tissue environment at high resolution. This chart reflects the market's willingness to pay for revenue in the high-tech equipment sector, demonstrating confidence in the revolutionary potential of Akoya's technologies for biomedical research.
P/S of the market as a whole
Akoya Biosciences provides spatial biology solutions that enable researchers to visualize and analyze cells in tissues at high resolution. The company's technologies are important for oncology and immunology. This chart shows the market premium for revenues of companies creating tools for scientific discovery.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company AKYA
Akoya Biosciences provides spatial biology solutions that analyze cells in the context of tissues. This chart shows how investors value the company based on its projected future sales of instruments and reagents. It reflects their belief in the growing demand for its technology in pharmaceutical research and diagnostics.
Future (projected) P/S of the market segment - Diagnostic medical equipment
Akoya Biosciences provides spatial biology solutions that enable the study of cells and biomarkers in the context of tissues. The chart shows the average estimated future revenue for diagnostic equipment manufacturers. It helps understand how investors value Akoya's technology platform and its role in scientific research and drug development.
Future (projected) P/S of the market as a whole
Akoya Biosciences (AKYA) provides spatial biology solutions that allow scientists to analyze cells in their natural environment. Their growth is driven by research spending in the pharmaceutical and academic sectors. This graph is important because economic growth supports R&D budgets.
Sales of the company, segment and market as a whole
Company sales AKYA
Akoya Biosciences' revenue is generated at the forefront of biological research. The company sells instruments and reagents that enable scientists to analyze proteins and cells in tissue samples with unprecedented detail. This growth reflects the growing demand for spatial biology technologies in oncology and immunology.
Sales of companies in the market segment - Diagnostic medical equipment
Akoya Biosciences provides spatial biology solutions that enable scientists to visualize cells in tissues at high resolution. Its revenue structure follows a "razor and blades" model: revenue comes from instrument sales and, more importantly, from consumables that ensure stable growth.
Overall market sales
Akoya Biosciences, Inc. provides spatial biology solutions, enabling scientists to analyze cells in the context of tissues. Demand for its platforms comes from research institutes and pharmaceutical companies. This graph, reflecting the overall state of the economy, influences the funding allocated to scientific research, which Akoya's client base depends on.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company AKYA
Akoya Biosciences provides spatial biology solutions, enabling researchers to analyze cells in the context of tissues. The company's sales are driven by R&D spending in biomedicine. This chart shows analysts' expectations for growth in this cutting-edge scientific market.
Future (projected) sales of companies in the market segment - Diagnostic medical equipment
Akoya Biosciences provides spatial biology solutions, enabling researchers to visualize cells and biomarkers in tissues. This graph shows the forecast for the medical diagnostics sector. It reflects the revolution in biomedical research, where spatial analysis is becoming a key tool.
Future (projected) sales of the market as a whole
Investments in biomedical research, which can be projected from this graph, determine the prospects of Akoya Biosciences. The company produces instruments for spatial biology. Demand for its equipment from laboratories and pharmaceutical companies is growing along with R&D budgets.
Marginality of the company, segment and market as a whole
Company marginality AKYA
Akoya Biosciences provides spatial biology solutions that enable researchers to study cells in their tissue context. This graph shows profitability in the cutting-edge biomedical research sector. Profitability depends on sales of its instruments and reagents to scientific and pharmaceutical laboratories.
Market segment marginality - Diagnostic medical equipment
Akoya Biosciences provides spatial biology solutions that enable researchers to visualize cells and biomarkers in tissues at high resolution. Profitability depends on sales of its instruments and reagents. This chart shows the average profitability in the sector. It helps assess the relevance of Akoya's technologies in scientific research.
Market marginality as a whole
Akoya Biosciences provides solutions for spatial tissue analysis, which is essential for oncology and immunology research. Demand for its platforms comes from research laboratories and pharmaceutical companies. This trend, reflecting the overall economic situation, impacts R&D budgets, which are the primary source of funding for the purchase of advanced scientific equipment.
Employees in the company, segment and market as a whole
Number of employees in the company AKYA
Akoya Biosciences provides spatial biology solutions, enabling scientists to visualize cells in tissues. This graph reflects the size of its team of scientists, engineers, and sales professionals. The growth in the graph demonstrates the growing demand for their technologies in pharmaceutical research and academia to accelerate discovery.
Share of the company's employees AKYA within the market segment - Diagnostic medical equipment
Akoya Biosciences provides spatial biology platforms that enable scientists to visualize cells and biomarkers in tissues with unprecedented detail. This chart shows the company's share of all researchers in this cutting-edge field, demonstrating its technological leadership in the new era of biomedical research.
Number of employees in the market segment - Diagnostic medical equipment
Akoya Biosciences provides spatial phenotyping solutions that enable the analysis of cells within the context of tissues. This chart, reflecting employment in the diagnostic equipment sector, is significant. The growing number of biologists and engineers in this cutting-edge niche is evidence of a revolution in biomedical research, where spatial analysis is becoming the new standard.
Number of employees in the market as a whole
Akoya Biosciences provides technologies for spatial biology, allowing scientists to study cells in their natural environment. This overall employment chart reflects the health of the R&D sector. Stable economic growth provides funding for scientific research at universities and pharmaceutical companies, which are Akoya's primary clients.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company AKYA (AKYA)
Akoya Biosciences (AKYA) is a life sciences company providing solutions for spatial biology (tissue analysis). Their value lies in their platform (instruments and reagents), which is their "intellectual capital." This metric reflects the high valuation of their research-changing technologies per employee.
Market capitalization per employee (in thousands of dollars) in the market segment - Diagnostic medical equipment
Akoya Biosciences provides solutions for spatial biology, enabling scientists to analyze tissues with unprecedented detail. The company's value lies in its unique tools and platform. This chart illustrates the market premium for advanced technologies in the life sciences industry, where the cost per employee can be very high.
Market capitalization per employee (in thousands of dollars) for the overall market
Akoya Biosciences produces spatial biology tools that allow scientists to analyze cells in the context of tissues. This is a cutting-edge field in biomedical research. The high employee rating reflects the value of its innovative platform, where a small team creates tools that accelerate scientific discoveries worldwide.
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company AKYA (AKYA)
Akoya Biosciences provides solutions for "spatial biology"โtechnologies that allow scientists to visualize how cells interact within tissues (such as tumors). It's a "pick-and-shovel" (instruments and reagents) R&D business. This chart shows how profitably their team sells these complex and expensive systems to the scientific community.
Profit per employee (in thousands of dollars) in the market segment - Diagnostic medical equipment
Akoya Biosciences provides spatial phenotyping solutions for analyzing cells in tissues. This chart reflects how efficiently the company sells its sophisticated scientific equipment and reagents. High profit per employee in this niche indicates strong demand from research labs and pharmaceutical companies.
Profit per employee (in thousands of dollars) for the market as a whole
Akoya Biosciences (AKYA) is a life science company producing instruments and reagents for spatial biology (tissue analysis at the cell level). It is a MedTech company. This chart shows how the manufacturer of complex scientific equipment generates profits from its employees (engineers, scientists, and salespeople).
Sales to employees of the company, segment and market as a whole
Sales per company employee AKYA (AKYA)
Akoya Biosciences provides spatial biology solutions, enabling scientists to visualize cells in tissues. This chart shows how the company is commercializing its cutting-edge scientific platform. The growth in revenue per employee demonstrates the demand for their tools in the research community.
Sales per employee in the market segment - Diagnostic medical equipment
Akoya Biosciences is a leader in the field of "spatial biology." Their platforms (microscopes and reagents) allow scientists to see how cells interact in tissues (for example, tumors). This graph shows how productive their team (R&D, manufacturing, sales) is. It reflects their ability to sell expensive "instruments" and "consumables."
Sales per employee for the market as a whole
Gogo (GOGO) is a leading provider of in-flight connectivity (IFC) services, specializing in the business aviation market (private jets). This chart demonstrates the effectiveness of their network model. Gogo owns and operates a network of ATGs and satellite links. Subscription revenue grows with each connected aircraft, while the network management staff remains stable.
Short shares by company, segment and market as a whole
Shares shorted by company AKYA (AKYA)
Akoya (AKYA) produces equipment for "spatial biology"โa complex scientific analysis. This chart shows the volume of short positions. Bears may believe the company, while suffering losses, is overvalued, or that sales of its expensive equipment will be slower than expected.
Shares shorted by market segment - Diagnostic medical equipment
Akoya Biosciences (AKYA) provides spatial biology solutions, allowing scientists to visualize cells in tissues. The chart below shows the overall short position in the "life sciences tools" sector. It shows whether investors expect R&D budgets in biotech and scientific institutions to be cut.
Shares shorted by the overall market
Akoya (AKYA) is an R&D project in the field of genomics. It's a "shovel" for biotech. When this chart shows rising fear, it signals a "venture winter." This means that AKYA's clients (small biotechs) are freezing R&D and stopping buying its expensive, unproven equipment.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator AKYA (AKYA)
This chart for Akoya is an indicator of demand for spatial biology. The company produces equipment (PhenoCycler/Imager) for complex tissue analysis, which is important for drug development. "Overbought" levels (above 70) arise from strong instrument sales reports. High equipment costs and competition lead to "oversold" levels (below 30).
RSI 14 Market Segment - Diagnostic medical equipment
Akoya is a "microscope" 2.0 ("Spatial biology"). Their *platform* (PhenoCycler/Imager) allows scientists *"see"* cells *within* tissue *in 3D* (for R&D). The "Diagnostic medical equipment" (medtech) sector thrives on R&D. RSI_14_Seg shows whether the *entire* sector is "overbought." This helps differentiate: is AKYA's growth a niche or a general "overheating"?
RSI 14 for the overall market
Akoya Biosciences (AKYA) is a biotech company. Like everything in its sector, it's critically dependent on this schedule. Market euphoria offers the potential to easily raise hundreds of millions of dollars for research. Market panic risks running out of money before its breakthrough technologies reach patients.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast AKYA (AKYA)
Akoya Biosciences is a leader in "spatial biology," providing scientists with tools (PhenoCycler, PhenoImager) for analyzing cells in tissues. This chart shows how analysts, on average, estimate the speed of adoption of their platforms in R&D labs. Their target price is a collective bet on whether this technology will become a standard in biotech.
The difference between the consensus estimate and the actual stock price AKYA (AKYA)
Akoya (AKYA) is a biotech "artist." Their "spatial biology" platforms allow scientists to visualize how cells interact in tumors. This chart shows how the current share price differs from the "fair" value predicted by analysts. It reflects their belief that this expensive R&D technology will become a new standard in oncology.
Analyst consensus forecast for stock prices by market segment - Diagnostic medical equipment
Akoya Biosciences is a pioneer in "spatial biology," whose Phenom devices allow scientists to "map" cancer at the cellular level. This is a complex R&D market. This chart shows what analysts expect from the entire diagnostic equipment sector. It reflects whether experts believe R&D budgets for biotech hardware will grow.
Analysts' consensus forecast for the overall market share price
Akoya Biosciences (AKYA) is a pioneer in "spatial biology." Their instruments are like "Google Maps" for cells: they allow scientists to see how cells interact within tissue, which is crucial for oncology R&D. This chart shows the overall risk appetite in the market. It reflects how confident analysts are in the stability of R&D budgets for "big pharma," AKYA's clients.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index AKYA
Akoya Biosciences is a leader in spatial biology. Their tools (Phenom) are essentially Google Maps for cells, allowing scientists to see how cells interact in tumors. This graph is a summary of their implementation history. It reflects their ability to sell expensive razors (devices) and blades (reagents) to R&D labs around the world.
AKIMA Market Segment Index - Diagnostic medical equipment
Akoya Biosciences is a pioneer in spatial biology. Their equipment allows scientists to not just count cells, but also see their precise locations and interactions within tissues. This is a revolution in cancer diagnostics. How effective is this cutting-edge, yet complex, technology? This chart compares the company's composite index to the sector average, showing whether AKYA is outperforming its competitors.
The AKIM Index for the overall market
Akoya Biosciences is a spatial biology company providing tissue imaging and biomarker analysis solutions. This chart, which reflects the market average, is a backdrop. It helps assess how AKYA, a tool for cancer researchers, compares to overall macroeconomic trends.